Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
The Drugs Consensus Is Not Pretty - It's Been Ripped Apart at the Seams

The UNGASS was certainly not a success for the defenders of the status quo. The consensus on punitive prohibition has been well and truly ripped apart at the seams. This UNGASS demonstrates the impact civil society pressure can achieve. The drug policy reform movement will continue to grow into a formidable global social movement towards 2019. The collective demand for change will grow ever louder leading to sustainable and seismic break-throughs at national, regional and ultimately UN levels.

Published
16 hours ago
From
International Drug Policy Consortium
First Canadian Study Demonstrates Potential to Remove Patients from Active Liver Transplant List After Curing Hepatitis C

Researchers with the Multi-Organ Transplant Program at London Health Sciences Centre and the Lawson Health Research Institute have been able to remove one-third (33 per cent) of patients from the active liver transplant waiting list by "curing" them of their Hepatitis C disease.

Published
03 May 2016
From
Lawson Health Research Institute press release
'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Merck & Co. has yet to report first-quarter earnings, so industry watchers still don’t know exactly how much market share the company’s new hep C combo treatment, Zepatier, has scored since winning approval in late January. But so far, comments from its competitors suggest it’s doing pretty well for itself.

Published
03 May 2016
From
Fierce Pharma
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
AIDS expert to head $5-million research efforts on hepatitis C

Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and men who have sex with men. It will concentrate on people who have already taken medication that clears them of the hepatitis C virus, but who could be reinfected if they have blood-to-blood contact with another person. They will be encouraged to prevent that by using condoms, not sharing needles and taking part in support programs through Vancouver Coastal Health, one of the five organizations involved in the program.

Published
22 April 2016
From
Vancouver Sun
Hepatitis C: no more treatment rationing; universal access to generic medicines everywhere!

People with hepatitis C virus (HCV) and their allies from Spain and around the world have gathered at the International Liver Congress to protest the outrageous price of life-saving HCV medicines. They are pushing for generic competition to bring down the price of HCV treatment and ensure universal access.

Published
18 April 2016
From
Treatment Action Group
Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

Published
14 April 2016
From
World Hepatitis Alliance
Research shows doctors are failing to diagnose more than 50% of patients with hepatitis C virus (HCV)

Survey results show people living with HCV in the UK, the Netherlands and Belarus are less likely to be diagnosed than their global counterparts, increasing the possibility of liver disease, cirrhosis and liver cancer. Findings from HCV Quest, a global patient survey with 4,000 respondents from across the world, showed that half of people diagnosed with HCV reported that their doctors had initially failed to recognise symptoms and less than 46% were referred for a test.

Published
14 April 2016
From
World Hepatitis Alliance
Hepatitis C: The task now is identifying people who don’t know they’re infected and connecting them to care

Interview with Luis Mendão, chair of both the European AIDS Treatment Group (EATG) and Group of Activists on Treatments (GAT), a treatment activist group in Portugal.

Published
14 April 2016
From
BioMed Central blogs
Hepatitis C: Let’s not forget ‘prevention as prevention’

Interview with Eberhard Schatz, one of the two coordinators of Correlation, the European social inclusion and health network.

Published
14 April 2016
From
BioMed Central blogs
← First12345...111Next →

Filter by country